OPKO Health, Inc. (LON:0KCS)
London
· Delayed Price · Currency is GBP · Price in USD 1.431
-0.029 (-1.99%)
At close: Apr 24, 2025
OPKO Health Revenue
In the year 2024, OPKO Health had annual revenue of $713.14M USD, down -17.41%. OPKO Health had revenue of $183.64M in the quarter ending December 31, 2024, with 0.95% growth.
Revenue
$713.14M
Revenue Growth
-17.41%
P/S Ratio
1.30
Revenue / Employee
$237.95K
Employees
2,997
Market Cap
743.22M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
OPKO Health News
- 20 days ago - OPKO Health authorizes $100 million increase to share buyback program - Seeking Alpha
- 20 days ago - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewsWire
- 5 weeks ago - OPKO and Entera partner to develop obesity pill - Reuters
- 5 weeks ago - Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More. - Barron's
- 6 weeks ago - Labcorp to buy certain assets of OPKO unit BioReference Health - Seeking Alpha
- 6 weeks ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 7 weeks ago - Decoding OPKO Health Inc (OPK): A Strategic SWOT Insight - GuruFocus
- 7 weeks ago - Opko Health (OPK) Q4 2024 Earnings Call Transcript - The Motley Fool